Evidence map›Paper›PMID 28792282›Full record

ArticleJournal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism2019

Anti-inflammation conferred by stimulation of CD200R1 via Dok1 pathway in rat microglia after germinal matrix hemorrhage.

Zhanhui Feng, Lan Ye, Damon Klebe, Yan Ding, Zhen-Ni Guo, Jerry J Flores, Cheng Yin, Jiping Tang, John H Zhang

Open access · bronzeAbstract read
In one paragraph

Article in Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Germinal matrix hemorrhage induces immune responses, brain injury, and motor impairment in neonatal rats.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2023
    Article
  4. Article
  5. Article
  6. Review
  7. HDAC inhibition reduces white matter injury after intracerebral hemorrhage.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2021
    Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Zhanhui Feng1 Department of Neurology, Affiliated Hospital of Guizhou Medical University, Guiyang, China.
Lan Ye2 Department of Basic Sciences, Loma Linda University School of Medicine, Loma Linda, CA, USA.
Damon Klebe2 Department of Basic Sciences, Loma Linda University School of Medicine, Loma Linda, CA, USA.
Yan Ding2 Department of Basic Sciences, Loma Linda University School of Medicine, Loma Linda, CA, USA.
Zhen-Ni Guo2 Department of Basic Sciences, Loma Linda University School of Medicine, Loma Linda, CA, USA.
Jerry J Flores2 Department of Basic Sciences, Loma Linda University School of Medicine, Loma Linda, CA, USA.
Cheng Yin2 Department of Basic Sciences, Loma Linda University School of Medicine, Loma Linda, CA, USA.
Jiping Tang2 Department of Basic Sciences, Loma Linda University School of Medicine, Loma Linda, CA, USA.
John H Zhang2 Department of Basic Sciences, Loma Linda University School of Medicine, Loma Linda, CA, USA.
Loma Linda University · USAffiliated Hospital of Guizhou Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

CD200 has been reported to be neuroprotective in neurodegenerative diseases. However, the potential protective effects of CD200 in germinal matrix hemorrhage (GMH) have not been investigated. We examined the anti-inflammatory mechanisms of CD200 after GMH. A total of 167 seven-day-old rat pups were used. The time-dependent effect of GMH on the levels of CD200 and CD200 Receptor 1 (CD200R1) was evaluated by western blot. CD200R1 was localized by immunohistochemistry. The short-term (24 h) and long-term (28 days) outcomes were evaluated after CD200 fusion protein (CD200Fc) treatment by neurobehavioral assessment. CD200 small interfering RNA (siRNA) and downstream of tyrosine kinase 1 (Dok1) siRNA were injected intracerebroventricularly. Western blot was employed to study the mechanisms of CD200 and CD200R1. GMH induced significant developmental delay and caused impairment in both cognitive and motor functions in rat pups. CD200Fc ameliorated GMH-induced damage. CD200Fc increased expression of Dok1 and decreased IL-1beta and TNF-alpha levels. CD200R1 siRNA and Dok1 siRNA abolished the beneficial effects of CD200Fc, as demonstrated by enhanced expression levels of IL-1beta and TNF-alpha. CD200Fc inhibited GMH-induced inflammation and this effect may be mediated by CD200R1/Dok1 pathway. Thus, CD200Fc may serve as a potential treatment to ameliorate brain injury for GMH patients.

Indexed as

AnimalsAnimals, NewbornBlood-Brain BarrierCerebral HemorrhageDevelopmental DisabilitiesDNA-Binding ProteinsImmunoglobulin GImmunohistochemistryInflammationInjections, IntraventricularInterleukin-1betaMicrogliaPhosphoproteinsRatsReceptors, ImmunologicRNA-Binding ProteinsCD200-FC, mouseCd200 protein, ratDNA-Binding ProteinsDok1 protein, ratImmunoglobulin GInterleukin-1betaPhosphoproteinsReceptors, ImmunologicRNA-Binding ProteinsRNA, Small InterferingTumor Necrosis Factor-alphaCD200CD200Receptor 1downstream of tyrosine kinase 1Germinal matrix hemorrhagemicroglia

Identifiers

PMID28792282
PMCPMC6311673
OpenAlexW2743892970

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.